Skip to main content

Evolution of the concept of focal therapy for prostate cancer.

Publication ,  Journal Article
Tsivian, M; Abern, MR; Polascik, TJ
Published in: Oncology (Williston Park)
January 2013

The landscape of prostate cancer has been rapidly evolving, and technological advances in imaging and biopsy tools offer novel approaches to focal therapy. In this dynamic environment, the role of focal therapy for prostate cancer is being shaped both by advances in technology and by reconsidering the epidemiological and outcomes data for available treatments. Here we focus on the evolution of the concept of focal therapy and its potential roles in the management of prostate cancer.

Duke Scholars

Published In

Oncology (Williston Park)

ISSN

0890-9091

Publication Date

January 2013

Volume

27

Issue

1

Start / End Page

64 / 70

Location

United States

Related Subject Headings

  • Prostatic Neoplasms
  • Patient Selection
  • Male
  • Humans
  • Clinical Trials as Topic
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tsivian, M., Abern, M. R., & Polascik, T. J. (2013). Evolution of the concept of focal therapy for prostate cancer. Oncology (Williston Park), 27(1), 64–70.
Tsivian, Matvey, Michael R. Abern, and Thomas J. Polascik. “Evolution of the concept of focal therapy for prostate cancer.Oncology (Williston Park) 27, no. 1 (January 2013): 64–70.
Tsivian M, Abern MR, Polascik TJ. Evolution of the concept of focal therapy for prostate cancer. Oncology (Williston Park). 2013 Jan;27(1):64–70.
Tsivian, Matvey, et al. “Evolution of the concept of focal therapy for prostate cancer.Oncology (Williston Park), vol. 27, no. 1, Jan. 2013, pp. 64–70.
Tsivian M, Abern MR, Polascik TJ. Evolution of the concept of focal therapy for prostate cancer. Oncology (Williston Park). 2013 Jan;27(1):64–70.

Published In

Oncology (Williston Park)

ISSN

0890-9091

Publication Date

January 2013

Volume

27

Issue

1

Start / End Page

64 / 70

Location

United States

Related Subject Headings

  • Prostatic Neoplasms
  • Patient Selection
  • Male
  • Humans
  • Clinical Trials as Topic